Lightrock Netherlands’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.4M Sell
361,266
-42,500
-11% -$4.4M 0.87% 34
2026
Q1
$3.78M Sell
403,766
-26,234
-6% -$2.69M 0.81% 36
2025
Q4
$3.85M Buy
430,000
+336,694
+361% +$39M 0.8% 39
2025
Q3
$10.1M Buy
93,306
+10,300
+12% +$1.23M 2.64% 15
2025
Q2
$8.67M Sell
83,006
-20,000
-19% -$2.28M 2.39% 21
2025
Q1
$10.4M Buy
103,006
+25,465
+33% +$2.49M 2.75% 16
2024
Q4
$7.2M Buy
+77,541
New +$7.61M 2.52% 20

Other funds holding EHC

Lightrock Netherlands's EHC Position: Q2 2026 in Review

Lightrock Netherlands reduced its Encompass Health (EHC) stake by 11% in Q2 2026, selling an estimated $4.4M and leaving 361,266 shares worth $4.4M. The position accounts for 0.87% of the portfolio, ranked #34.

Lightrock Netherlands first reported a position in EHC in Q4 2024 and has held it in 7 quarters since. The position peaked at $10.4M in Q1 2025. 314 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Lightrock Netherlands held 361,266 shares of Encompass Health worth $4.4M as of Q2 2026.
  • Lightrock Netherlands sold 42,500 Encompass Health shares in Q2 2026, an estimated $4.4M.
  • Encompass Health made up 0.87% of Lightrock Netherlands's portfolio in Q2 2026, its #34 holding.
  • Lightrock Netherlands first reported a position in Encompass Health in Q4 2024 and has held it in 7 quarters since.
  • Lightrock Netherlands's Encompass Health position peaked at $10.4M in Q1 2025.
  • 314 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Lightrock Netherlands's 13F filing for Q2 2026, filed 10 Aug 2026.